Skip to main content

Stifel Sees Challenging Road Ahead For vTv Therapeutics After Failed Alzheimer's Trial

By: via Benzinga
vTv Therapeutics Inc (NASDAQ: VTVT) announced Monday after the close that results from Part A of its late-stage study of an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.